» Articles » PMID: 20863784

Antihyperglycaemic, Antilipid Peroxidative and Antioxidant Effects of Gallic Acid on Streptozotocin Induced Diabetic Wistar Rats

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2010 Sep 25
PMID 20863784
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aims to evaluate the antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic male Wistar rats. To induce diabetes mellitus, rats were injected with streptozotocin intraperitoneally at a single dose of 40mg/kg. Streptozotocin induced diabetic rats showed significant (P<0.05) increase in the levels of blood glucose, glycosylated haemoglobin and significant (P<0.05) decrease in the levels of plasma insulin, body weight and total haemoglobin. Diabetic rats also showed significant (P<0.05) decrease in the activity of hepatic hexokinase and significant (P<0.05) increase in the activities of glucose-6-phosphatase and fructose-1, 6-bisphosphatase. The pancreatic thiobarbituric acid reactive substances and lipid hydroperoxides were significantly (P<0.05) increased and the activities of pancreatic superoxide dismutase, catalase and glutathione peroxidase were significantly (P<0.05) decreased in diabetic rats. Oral treatment with gallic acid (10 and 20mg/kg) daily for a period of 21days showed significant (P<0.05) protective effects on all the biochemical parameters studied. Histopathology of pancreas confirmed the protective effects of gallic acid in diabetic rats. In vitro study also revealed the potent antioxidant effect of gallic acid. Thus, the study shows the antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic rats. The effect exerted by 20mg/kg body weight of gallic acid was more effective than 10mg/kg body weight of gallic acid.

Citing Articles

Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.

Martiniakova M, Sarocka A, Penzes N, Biro R, Kovacova V, Mondockova V Nutrients. 2025; 17(2).

PMID: 39861406 PMC: 11767469. DOI: 10.3390/nu17020275.


Gallic acid: a dietary metabolite's therapeutic potential in the management of atherosclerotic cardiovascular disease.

Zhao X, Cao Z, Li K, Tang F, Xu L, Zhang J Front Pharmacol. 2025; 15():1515172.

PMID: 39840111 PMC: 11747375. DOI: 10.3389/fphar.2024.1515172.


Profiling of Potential Anti-Diabetic Active Compounds in White Tea: An Integrated Study of Polyphenol-Targeted Metabolomics, Network Pharmacology, and Computer Simulation.

Wu W, Zheng Z, Wang Z, Gao C, Liang Y, Zeng W Foods. 2024; 13(21).

PMID: 39517138 PMC: 11545757. DOI: 10.3390/foods13213354.


Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis.

Zhou X, Cao H, Liao T, Hua W, Zhao R, Wang D Noncoding RNA Res. 2024; 10:163-176.

PMID: 39399379 PMC: 11470567. DOI: 10.1016/j.ncrna.2024.07.005.


A novel Co/Zn-ferrite molecularly imprinted polymer-based electrochemical assay for sensing of gallic acid in plant extracts, wine, and herbal supplement.

Grujicic M, Yayla S, Cetinkaya A, Hurkul M, Jovanovic S, Ozkan S Anal Bioanal Chem. 2024; 417(7):1327-1339.

PMID: 39367909 DOI: 10.1007/s00216-024-05574-5.